Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Cancers|February 12, 2021
Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline GliomaArthur Wingerter, Khalifa El Malki, Roger Sandhoff, et al.Blood Advances|November 26, 2019
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivityFranziska Schramm, Udo Zur Stadt, Martin Zimmermann, et al.Cancers|March 28, 2025
The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor EntitiesLarissa Seidmann, Arthur Wingerter, Marie Oliver Metzig, et al.Cancers|December 23, 2022
GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of SubtypeClaudia Paret, Arsenij Ustjanzew, Sara Ersali, et al.Journal of the American Heart Association|February 24, 2021
Promotion of Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-Term SurvivorsNatalie Arnold, Hiltrud Merzenich, Arthur Wingerter, et al.International Journal of Molecular Sciences|September 5, 2019
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain TumorAlexandra Russo, Claudia Paret, Francesca Alt, et al.BMC Pediatrics|February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational studyJulia Roick, Reinhard Berner, Toralf Bernig, et al.Nature Communications|September 22, 2022
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistanceMariela Cortés-López, Laura Schulz, Mihaela Enculescu, et al.Acta Neuropathologica|January 22, 2021
Supratentorial ependymoma in childhood: more than just RELA or YAPValentina Zschernack, Stephanie T Jünger, Martin Mynarek, et al.Cancers|March 12, 2020
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell BiologyGabriele Calaminus, Dominik T Schneider, Dietrich von Schweinitz, et al.Pageof 9